MedTrace Logo

Effect of Morning Versus Evening Perindopril on Blood Pressure Control in People With Type 2 Diabetes

NCT03393715 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2018-01-08

No results posted yet for this study

Summary

We assessed the influence of time of administration of ACE inhibitors on circadian blood pressure control in sub Saharan type 2 diabetes patients with stage 1 hypertension over 56 days as first line treatment.

Conditions

Interventions

DRUG

Perindopril Oral Tablet

Perindopril oral tablet morning versus evening

Sponsors & Collaborators

  • University of Yaounde 1

    collaborator OTHER

  • Yaounde Central Hospital

    lead OTHER_GOV

Principal Investigators

  • Eugène Sobngwi, MD, PhD · Yaounde Central Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2016-07-31
Completion
2016-08-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03393715 on ClinicalTrials.gov